MicroRNAs and human retroviruses

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 11-12, 2011, Pages 686-693

  Houzet, Laurent ^a   Jeang, Kuan Teh ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Innate immunity; MicroRNA; RNA silencing suppressor; Viral gene expression; Virus replication; Virus host interaction

Indexed keywords

MICRORNA; RNA SILENCING SUPPRESSOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROVIRUS; REVIEW; RNA INTERFERENCE; SUPPRESSOR GENE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MICRORNAS; MODELS, GENETIC; RETROVIRIDAE; RNA INTERFERENCE; RNA, VIRAL; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; MAMMALIA;

EID: 80655124689     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2011.05.009     Document Type: Review

References (111)

1. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
2. Chua J.H., Armugam A., Jeyaseelan K. MicroRNAs: biogenesis, function and applications. Curr. Opin. Mol. Ther. 2009, 11:189-199.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Haase A.D., Jaskiewicz L., Zhang H., Laine S., Sack R., Gatignol A., Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005, 6:961-967.
5. Gatignol A., Buckler-White A., Berkhout B., Jeang K.T. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 1991, 251:1597-1600.
6. Chi Y.H., Jeang K.T., Semmes O.J. A proteomic study of TAR-RNA binding protein (TRBP)-associated factors. Cell Biosci. 2011, 1.
7. Wienholds E., Koudijs M.J., van Eeden F.J., Cuppen E., Plasterk R.H. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat. Genet. 2003, 35:217-218.
8. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., Mills A.A., Elledge S.J., Anderson K.V., Hannon G.J. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
9. Harfe B.D., McManus M.T., Mansfield J.H., Hornstein E., Tabin C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10898-10903.
10. Harris K.S., Zhang Z., McManus M.T., Harfe B.D., Sun X. Dicer function is essential for lung epithelium morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2208-2213.
11. Andl T., Murchison E.P., Liu F., Zhang Y., Yunta-Gonzalez M., Tobias J.W., Andl C.D., Seykora J.T., Hannon G.J., Millar S.E. The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr. Biol. 2006, 16:1041-1049.
12. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 2005, 202:261-269.
13. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15524-15529.
14. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2999-3004.
15. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
16. Lever A.M., Jeang K.T. Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry 2011, 50:920-931.
17. Umbach J.L., Cullen B.R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009, 23:1151-1164.
18. Grassmann R., Jeang K.T. The roles of microRNAs in mammalian virus infection. Biochim. Biophys. Acta 2008, 1779:706-711.
19. Yeung M.L., Benkirane M., Jeang K.T. Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?. Retrovirology 2007, 4:74.
20. Watanabe Y., Kishi A., Yachie N., Kanai A., Tomita M. Computational analysis of microRNA-mediated antiviral defense in humans. FEBS Lett. 2007, 581:4603-4610.
21. Berkhout B., Jeang K.T. RISCy business: microRNAs, pathogenesis, and viruses. J. Biol. Chem. 2007, 282:26641-26645.
22. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saib A., Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308:557-560.
23. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005, 309:1577-1581.
24. Zhang G.L., Li Y.X., Zheng S.Q., Liu M., Li X., Tang H. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res. 2010, 88:169-175.
25. Potenza N., Papa U., Mosca N., Zerbini F., Nobile V., Russo A. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res. Feb 11 2011, [Epub ahead of print].
26. Zheng S.Q., Li Y.X., Zhang Y., Li X., Tang H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res. 2011, 89:219-226.
27. Song L., Liu H., Gao S., Jiang W., Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J. Virol. 2010, 84:8849-8860.
28. Bivalkar-Mehla S., Vakharia J., Mehla R., Abreha M., Kanwar J.R., Tikoo A., Chauhan A. Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system. Virus Res. 2011, 155:1-9.
29. Delgadillo M.O., Saenz P., Salvador B., Garcia J.A., Simon-Mateo C. Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants. J. Gen. Virol. 2004, 85:993-999.
30. Haasnoot J., de Vries W., Geutjes E.J., Prins M., de Haan P., Berkhout B. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 2007, 3:e86.
31. Wang Y., Kato N., Jazag A., Dharel N., Otsuka M., Taniguchi H., Kawabe T., Omata M. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 2006, 130:883-892.
32. Bennasser Y., Le S.Y., Benkirane M., Jeang K.T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005, 22:607-619.
33. Abe M., Suzuki H., Nishitsuji H., Shida H., Takaku H. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing. FEBS Lett. 2010, 584:4313-4318.
34. Lu S., Cullen B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J. Virol. 2004, 78:12868-12876.
35. Cai R., Carpick B., Chun R.F., Jeang K.T., Williams B.R. HIV-I Tat inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch. Biochem. Biophys. 2000, 373:361-367.
36. McMillan N.A., Chun R.F., Siderovski D.P., Galabru J., Toone W.M., Samuel C.E., Mak T.W., Hovanessian A.G., Jeang K.T., Williams B.R. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 1995, 213:413-424.
37. Triboulet R., Mari B., Lin Y.L., Chable-Bessia C., Bennasser Y., Lebrigand K., Cardinaud B., Maurin T., Barbry P., Baillat V., Reynes J., Corbeau P., Jeang K.T., Benkirane M. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315:1579-1582.
38. Chable-Bessia C., Meziane O., Latreille D., Triboulet R., Zamborlini A., Wagschal A., Jacquet J.M., Reynes J., Levy Y., Saib A., Bennasser Y., Benkirane M. Suppression of HIV-1 replication by microRNA effectors. Retrovirology 2009, 6:26.
39. Qian S., Zhong X., Yu L., Ding B., de Haan P., Boris-Lawrie K. HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:605-610.
40. Yeung M.L., Bennasser Y., Watashi K., Le S.Y., Houzet L., Jeang K.T. Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res. 2009, 37:6575-6586.
41. Pederson T. Regulatory RNAs derived from transfer RNA?. RNA 2010, 16:1865-1869.
42. Lindow M., Gorodkin J. Principles and limitations of computational microRNA gene and target finding. DNA Cell Biol. 2007, 26:339-351.
43. Hariharan M., Scaria V., Pillai B., Brahmachari S.K. Targets for human encoded microRNAs in HIV genes. Biochem. Biophys. Res. Commun. 2005, 337:1214-1218.
44. Nathans R., Chu C.Y., Serquina A.K., Lu C.C., Cao H., Rana T.M. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 2009, 34:696-709.
45. Ahluwalia J.K., Khan S.Z., Soni K., Rawat P., Gupta A., Hariharan M., Scaria V., Lalwani M., Pillai B., Mitra D., Brahmachari S.K. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008, 5:117.
46. + T lymphocytes. Nat. Med. 2007, 13:1241-1247.
47. Wang X., Ye L., Hou W., Zhou Y., Wang Y.J., Metzger D.S., Ho W.Z. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009, 113:671-674.
48. Wang X., Ye L., Zhou Y., Liu M.Q., Zhou D.J., Ho W.Z. Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am. J. Pathol. 2011, 178:41-47.
49. Sung T.L., Rice A.P. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of Cyclin T1. PLoS Pathog. 2009, 5:e1000263.
50. Schnettler E., de Vries W., Hemmes H., Haasnoot J., Kormelink R., Goldbach R., Berkhout B. The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep. 2009, 10:258-263.
51. de Vries W., Haasnoot J., Fouchier R., de Haan P., Berkhout B. Differential RNA silencing suppression activity of NS1 proteins from different influenza A virus strains. J. Gen. Virol. 2009, 90:1916-1922.
52. Bennasser Y., Yeung M.L., Jeang K.T. HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J. Biol. Chem. 2006, 281:27674-27678.
53. Westerhout E.M., ter Brake O., Berkhout B. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology 2006, 3:57.
54. Strebel K., Luban J., Jeang K.T. Human cellular restriction factors that target HIV-1 replication. BMC Med. 2009, 7:48.
55. Lin J., Cullen B.R. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J. Virol. 2007, 81:12218-12226.
56. Hemmes H., Lakatos L., Goldbach R., Burgyan J., Prins M. The NS3 protein of rice hoja blanca tenuivirus suppresses RNA silencing in plant and insect hosts by efficiently binding both siRNAs and miRNAs. RNA 2007, 13:1079-1089.
57. Merai Z., Kerenyi Z., Kertesz S., Magna M., Lakatos L., Silhavy D. Double-stranded RNA binding may be a general plant RNA viral strategy to suppress RNA silencing. J. Virol. 2006, 80:5747-5756.
58. Silhavy D., Molnar A., Lucioli A., Szittya G., Hornyik C., Tavazza M., Burgyan J. A viral protein suppresses RNA silencing and binds silencing-generated, 21- to 25-nucleotide double-stranded RNAs. EMBO J. 2002, 21:3070-3080.
59. Lichner Z., Silhavy D., Burgyan J. Double-stranded RNA-binding proteins could suppress RNA interference-mediated antiviral defences. J. Gen. Virol. 2003, 84:975-980.
60. Rawlings R.A., Krishnan V., Walter N.G. Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover. J. Mol. Biol. Apr 29 2011, 408(2):262-276.
61. Watashi K., Yeung M.L., Starost M.F., Hosmane R.S., Jeang K.T. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J. Biol. Chem. 2010, 285:24707-24716.
62. Andersson M.G., Haasnoot P.C., Xu N., Berenjian S., Berkhout B., Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 2005, 79:9556-9565.
63. Berkhout B., Silverman R.H., Jeang K.T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989, 59:273-282.
64. Kao S.Y., Calman A.F., Luciw P.A., Peterlin B.M. Anti-termination of transcription within the long terminal repeat of HIV-1 by Tat gene product. Nature 1987, 330:489-493.
65. Das A.T., Brummelkamp T.R., Westerhout E.M., Vink M., Madiredjo M., Bernards R., Berkhout B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 2004, 78:2601-2605.
66. Boden D., Pusch O., Lee F., Tucker L., Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 2003, 77:11531-11535.
67. Leonard J.N., Shah P.S., Burnett J.C., Schaffer D.V. HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 2008, 4:484-494.
68. Westerhout E.M., Ooms M., Vink M., Das A.T., Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005, 33:796-804.
69. Yeung M.L., Bennasser Y., Myers T.G., Jiang G., Benkirane M., Jeang K.T. Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2005, 2:81.
70. Houzet L., Yeung M.L., de Lame V., Desai D., Smith S.M., Jeang K.T. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 2008, 5:118.
71. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
72. Grundhoff A., Sullivan C.S. Virus-encoded microRNAs. Virology Mar 15 2011, 411(2):325-343.
73. Boss I.W., Plaisance K.B., Renne R. Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol. 2009, 17:544-553.
74. Liu Y.P., Vink M.A., Westerink J.T., Ramirez de Arellano E., Konstantinova P., Ter Brake O., Berkhout B. Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies. RNA 2010, 16:1328-1339.
75. Bennasser Y., Le S.Y., Yeung M.L., Jeang K.T. HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 2004, 1:43.
76. Omoto S., Fujii Y.R. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J. Gen. Virol. 2005, 86:751-755.
77. Omoto S., Ito M., Tsutsumi Y., Ichikawa Y., Okuyama H., Brisibe E.A., Saksena N.K., Fujii Y.R. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 2004, 1:44.
78. Ouellet D.L., Plante I., Landry P., Barat C., Janelle M.E., Flamand L., Tremblay M.J., Provost P. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. 2008, 36:2353-2365.
79. Klase Z., Kale P., Winograd R., Gupta M.V., Heydarian M., Berro R., McCaffrey T., Kashanchi F. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol. Biol. 2007, 8:63.
80. Klase Z., Winograd R., Davis J., Carpio L., Hildreth R., Heydarian M., Fu S., McCaffrey T., Meiri E., Ayash-Rashkovsky M., Gilad S., Bentwich Z., Kashanchi F. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 2009, 6:18.
81. Matsuoka M., Jeang K.T. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene Mar 24 2011, 30(12):1379-1389.
82. Ruggero K., Corradin A., Zanovello P., Amadori A., Bronte V., Ciminale V., D'Agostino D.M. Role of microRNAs in HTLV-1 infection and transformation. Mol. Aspects Med. 2010, 31:367-382.
83. Hakim S.T., Alsayari M., McLean D.C., Saleem S., Addanki K.C., Aggarwal M., Mahalingam K., Bagasra O. A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses. Biochem. Biophys. Res. Commun. 2008, 369:357-362.
84. Yeung M.L., Yasunaga J., Bennasser Y., Dusetti N., Harris D., Ahmad N., Matsuoka M., Jeang K.T. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 2008, 68:8976-8985.
85. Bellon M., Lepelletier Y., Hermine O., Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009, 113:4914-4917.
86. Kapranov P., St Laurent G., Raz T., Ozsolak F., Reynolds C.P., Sorensen P.H., Reaman G., Milos P., Arceci R.J., Thompson J.F., Triche T.J. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol. 2010, 8:149.
87. Parameswaran P., Sklan E., Wilkins C., Burgon T., Samuel M.A., Lu R., Ansel K.M., Heissmeyer V., Einav S., Jackson W., Doukas T., Paranjape S., Polacek C., dos Santos F.B., Jalili R., Babrzadeh F., Gharizadeh B., Grimm D., Kay M., Koike S., Sarnow P., Ronaghi M., Ding S.W., Harris E., Chow M., Diamond M.S., Kirkegaard K., Glenn J.S., Fire A.Z. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 2010, 6:e1000764.
88. Matsuoka M., Green P.L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6:71.
89. Matsuoka M., Jeang K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7:270-280.
90. Peloponese J.M., Jeang K.T. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 Tax oncoprotein. J. Biol. Chem. 2006, 281:8927-8938.
91. Iha H., Kibler K.V., Yedavalli V.R., Peloponese J.M., Haller K., Miyazato A., Kasai T., Jeang K.T. Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling. Oncogene 2003, 22:8912-8923.
92. Rosin O., Koch C., Schmitt I., Semmes O.J., Jeang K.T., Grassmann R. A human T-cell leukemia virus Tax variant incapable of activating NF-kappaB retains its immortalizing potential for primary T-lymphocytes. J. Biol. Chem. 1998, 273:6698-6703.
93. Jin D.Y., Teramoto H., Giam C.Z., Chun R.F., Gutkind J.S., Jeang K.T. A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor alpha. J. Biol. Chem. 1997, 272:25816-25823.
94. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
95. Yasunaga J., Jeang K.T. Viral transformation and aneuploidy. Environ. Mol. Mutagen. 2009, 50:733-740.
96. Jeang K.T. HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30years after virus discovery. J. Formos. Med. Assoc. 2010, 109:688-693.
97. Jeang K.T. Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?. Oncotarget 2010, 1:453-456.
98. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
99. Millar A.A., Waterhouse P.M. Plant and animal microRNAs: similarities and differences. Funct. Integr. Genomics 2005, 5:129-135.
100. ter Brake O., t Hooft K., Liu Y.P., Centlivre M., von Eije K.J., Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 2008, 16:557-564.
101. Applegate T.L., Birkett D.J., McIntyre G.J., Jaramillo A.B., Symonds G., Murray J.M. In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. Retrovirology 2010, 7:83.
102. Schopman N.C., ter Brake O., Berkhout B. Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010, 7:52.
103. + cells. Nat. Med. 2009, 15:285-292.
104. Blow N.S. Our crystal ball. Biotechniques 2011, 50:77.
105. Fabozzi G., Nabel C.S., Dolan M.A., Sullivan N.J. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J. Virol. 2011, 85:2512-2523.
106. Karjee S., Minhas A., Sood V., Ponia S.S., Banerjea A.C., Chow V.T., Mukherjee S.K., Lal S.K. The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor. J. Virol. 2010, 84:10395-10401.
107. Ji J., Glaser A., Wernli M., Berke J.M., Moradpour D., Erb P. Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J. Gen. Virol. 2008, 89:2761-2766.
108. Soldan S.S., Plassmeyer M.L., Matukonis M.K., Gonzalez-Scarano F. La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J. Virol. 2005, 79:234-244.
109. Li W.X., Li H., Lu R., Li F., Dus M., Atkinson P., Brydon E.W., Johnson K.L., Garcia-Sastre A., Ball L.A., Palese P., Ding S.W. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1350-1355.
110. Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., Kang Y.J., Jiang Z., Du X., Cook R., Das S.C., Pattnaik A.K., Beutler B., Han J. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27:123-134.
111. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.